BRAF and neoplasm: Oliveira et al (7) reported 5 cases of BRAF V600E and oncogenic KRAS that preferentially coexisted in advanced colorectal carcinoma; one of the 5 cases harbored the KRAS G12A mutation, indicating that activation of the two genes plays a synergistic role in tumor progression.